Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| GALT | NASDAQ | Galectin Therapeutics Inc. | $3.47 | +0.58% | 313K | $228.52M |
| TRDA | NASDAQ | Entrada Therapeutics, Inc. | $6.05 | -1.63% | 566K | $227.1M |
| ACIU | NASDAQ | AC Immune S.A. | $2.23 | -0.45% | 384K | $226.96M |
| FOCL | NASDAQ | EDAP TMS S.A. American Depositary Shares | $5.46 | +0.83% | 48K | $226.02M |
| TARA | NASDAQ | Protara Therapeutics, Inc. | $4.04 | -0.98% | 435K | $225.94M |
| OBIO | NASDAQ | Orchestra BioMed Holdings, Inc. | $3.71 | +0.82% | 149K | $223.95M |
| SIGA | NASDAQ | SIGA Technologies, Inc. | $3.11 | -1.27% | 877K | $223.06M |
| AVXL | NASDAQ | Anavex Life Sciences Corp. | $2.40 | -3.23% | 1M | $222.41M |
| STRO | NASDAQ | Sutro Biopharma, Inc. | $26.03 | -6.50% | 328K | $221.42M |
| SPOK | NASDAQ | Spok Holdings, Inc. | $10.64 | -0.84% | 112K | $221.19M |
| PRLD | NASDAQ | Prelude Therapeutics Incorporated | $3.83 | -2.54% | 284K | $218.05M |
| CGEN | NASDAQ | Compugen Ltd. | $2.28 | -2.56% | 200K | $215.58M |
| RXST | NASDAQ | RxSight, Inc. | $4.93 | +0.20% | 843K | $214.85M |
| NAUT | NASDAQ | Nautilus Biotechnolgy, Inc. | $1.69 | -4.52% | 623K | $214.76M |
| UTMD | NASDAQ | Utah Medical Products, Inc. | $71.52 | +1.56% | 76K | $213.78M |
| AVTX | NASDAQ | Avalo Therapeutics, Inc. | $18.44 | +3.83% | 800K | $208.26M |
| NBP | NASDAQ | NovaBridge Biosciences | $1.82 | +0.83% | 199K | $204.02M |
| SENS | NASDAQ | Senseonics Holdings, Inc. | $4.86 | -0.21% | 454K | $203.12M |
| FULC | NASDAQ | Fulcrum Therapeutics, Inc. | $3.72 | -1.06% | 573K | $201.29M |
| ANIK | NASDAQ | Anika Therapeutics, Inc. | $15.06 | -1.25% | 45K | $198.92M |
| RNA | NASDAQ | Atrium Therapeutics, Inc. | $11.49 | -3.53% | 121K | $196.54M |
| EMBC | NASDAQ | Embecta Corp. | $3.29 | +1.23% | 737K | $195.19M |
| EPRX | NASDAQ | Eupraxia Pharmaceuticals Inc. | $6.24 | -2.88% | 893K | $194.52M |
| QTTB | NASDAQ | Q32 Bio Inc. | $13.43 | +2.56% | 179K | $193.56M |
| GLSI | NASDAQ | Greenwich LifeSciences, Inc. | $12.98 | -1.59% | 114K | $190.52M |
| VYGR | NASDAQ | Voyager Therapeutics, Inc. | $3.10 | +0.32% | 484K | $187.31M |
| WHWK | NASDAQ | Whitehawk Therapeutics Inc | $3.71 | -3.13% | 408K | $183.47M |
| MDWD | NASDAQ | MediWound Ltd. | $14.29 | -2.86% | 46K | $182.79M |
| IPSC | NASDAQ | Century Therapeutics, Inc. | $2.11 | -2.76% | 678K | $182.66M |
| IMUX | NASDAQ | Immunic, Inc. | $13.39 | -6.23% | 156K | $182.39M |
| PRQR | NASDAQ | ProQR Therapeutics N.V. | $1.77 | +4.12% | 567K | $181.13M |
| IVVD | NASDAQ | Invivyd, Inc. | $0.61 | +0.36% | 3.1M | $180.12M |
| MENS | NASDAQ | Jyong Biotech Ltd. Ordinary Shares | $2.36 | -12.92% | 58K | $179.43M |
| LFMD | NASDAQ | LifeMD, Inc. | $3.94 | -3.79% | 759K | $179.42M |
| CNXU | NASDAQ | Conexeu Sciences Inc. | $9.83 | -6.47% | 62K | $179.29M |
| BDSX | NASDAQ | Biodesix, Inc. | $22.00 | -1.43% | 91K | $179.09M |
| ANTX | NASDAQ | AN2 Therapeutics, Inc. | $4.92 | 0.00% | 128K | $177.2M |
| KRMD | NASDAQ | KORU Medical Systems, Inc. | $4.04 | +0.25% | 219K | $175.92M |
| PDEX | NASDAQ | Pro-Dex, Inc. | $54.93 | +0.48% | 97K | $175.38M |
| QTRX | NASDAQ | Quanterix Corporation | $3.67 | -6.38% | 424K | $172.88M |
| CHRS | NASDAQ | Coherus Oncology, Inc. | $1.41 | -1.40% | 446K | $172.6M |
| LENZ | NASDAQ | LENZ Therapeutics, Inc. | $4.96 | -4.25% | 1.4M | $171.82M |
| TRIB | NASDAQ | Trinity Biotech plc | $8.45 | -5.73% | 24K | $171.02M |
| DERM | NASDAQ | Journey Medical Corporation | $6.91 | -1.29% | 313K | $170.36M |
| CRBP | NASDAQ | Corbus Pharmaceuticals Holdings, Inc. | $9.17 | -1.61% | 173K | $169.9M |
| TNYA | NASDAQ | Tenaya Therapeutics, Inc. | $0.78 | +0.25% | 1.8M | $168.17M |
| KPTI | NASDAQ | Karyopharm Therapeutics Inc. | $7.41 | +4.51% | 900K | $167.93M |
| IPHA | NASDAQ | Innate Pharma S.A. | $1.75 | -1.41% | 2K | $167.15M |
| INGN | NASDAQ | Inogen, Inc. | $6.15 | -2.69% | 233K | $166.51M |
| ACB | NASDAQ | Aurora Cannabis Inc. | $2.67 | -0.74% | 1.2M | $165.39M |